ARTICLE | Clinical News
Pandemrix: Data
October 26, 2009 7:00 AM UTC
GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Product: Pandemrix ( GSK2340272A) Business: Infectious Molecular target: NA Description: Split-virion, adjuvanted swine influenza A (H1N1) vaccin...